NewslettersIntestinal Cell News SunRock Biopharma and Chime Biologics Announce Strategic Collaboration to Advance Development of Anti-CCR9 Antibody SRB5 By Noshin Noorjahan - October 24, 2025 0 33 SunRock Biopharma and Chime Biologics announced a strategic collaboration for the development of SRB5, a novel anti-CCR9 monoclonal antibody targeting IBD. [SunRock Biopharma] Press Release